BioCardia, Inc. Files 2024 10-K

Ticker: BCDA · Form: 10-K · Filed: Mar 26, 2025 · CIK: 925741

Biocardia, Inc. 10-K Filing Summary
FieldDetail
CompanyBiocardia, Inc. (BCDA)
Form Type10-K
Filed DateMar 26, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, biotech

TL;DR

BioCardia filed its 2024 10-K. Check financials.

AI Summary

BioCardia, Inc. filed its 2024 10-K on March 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Tiger X Medical, Inc., is involved in the biological products sector. Its principal executive offices are located at 320 Soquel Way, Sunnyvale, CA.

Why It Matters

This filing provides a comprehensive overview of BioCardia's financial performance, business operations, and risk factors for the fiscal year 2024, crucial for investors and stakeholders to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: medium — As a company in the biological products sector, BioCardia likely faces inherent risks related to research and development, regulatory approvals, and market competition.

Key Players & Entities

  • BioCardia, Inc. (company) — Filer
  • Tiger X Medical, Inc. (company) — Former company name
  • 320 Soquel Way, Sunnyvale, CA (location) — Business address
  • 2024-12-31 (date) — Fiscal year end
  • 20250326 (date) — Filing date

FAQ

What is BioCardia, Inc.'s primary business activity?

BioCardia, Inc. is primarily involved in the biological products sector, specifically classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.

When did BioCardia, Inc. file its 10-K report?

BioCardia, Inc. filed its 10-K report on March 26, 2025.

What is the fiscal year end for BioCardia, Inc.?

The fiscal year end for BioCardia, Inc. is December 31.

What is BioCardia, Inc.'s business address?

BioCardia, Inc.'s business address is 320 Soquel Way, Sunnyvale, CA 94085.

Has BioCardia, Inc. operated under any previous names?

Yes, BioCardia, Inc. has operated under previous names including Tiger X Medical, Inc., Cardo Medical, Inc., and CLICKNSETTLE COM INC.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 26, 2025 regarding BioCardia, Inc. (BCDA).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.